These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 18317983

  • 1. [Treatment of sialorrhea in patients under long-term ventilation].
    Winterholler M.
    Pneumologie; 2008 Mar; 62 Suppl 1():S39-42. PubMed ID: 18317983
    [Abstract] [Full Text] [Related]

  • 2. Sialorrhea: a management challenge.
    Hockstein NG, Samadi DS, Gendron K, Handler SD.
    Am Fam Physician; 2004 Jun 01; 69(11):2628-34. PubMed ID: 15202698
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Drooling of saliva: a review of the etiology and management options.
    Meningaud JP, Pitak-Arnnop P, Chikhani L, Bertrand JC.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jan 01; 101(1):48-57. PubMed ID: 16360607
    [Abstract] [Full Text] [Related]

  • 5. Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism.
    Mancini F, Zangaglia R, Cristina S, Sommaruga MG, Martignoni E, Nappi G, Pacchetti C.
    Mov Disord; 2003 Jun 01; 18(6):685-8. PubMed ID: 12784273
    [Abstract] [Full Text] [Related]

  • 6. Reduction of salivary flow with botulinum toxin: extended report on 33 patients with drooling, salivary fistulas, and sialadenitis.
    Ellies M, Gottstein U, Rohrbach-Volland S, Arglebe C, Laskawi R.
    Laryngoscope; 2004 Oct 01; 114(10):1856-60. PubMed ID: 15454785
    [Abstract] [Full Text] [Related]

  • 7. Salivary gland application of botulinum toxin for the treatment of sialorrhea.
    Fuster Torres MA, Berini Aytés L, Gay Escoda C.
    Med Oral Patol Oral Cir Bucal; 2007 Nov 01; 12(7):E511-7. PubMed ID: 17978775
    [Abstract] [Full Text] [Related]

  • 8. Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study.
    Lagalla G, Millevolte M, Capecci M, Provinciali L, Ceravolo MG.
    Mov Disord; 2006 May 01; 21(5):704-7. PubMed ID: 16440332
    [Abstract] [Full Text] [Related]

  • 9. Surgical management of chronic sialorrhea in pediatric patients: 10-year experience from one tertiary care institution.
    Formeister EJ, Dahl JP, Rose AS.
    Int J Pediatr Otorhinolaryngol; 2014 Aug 01; 78(8):1387-92. PubMed ID: 24974144
    [Abstract] [Full Text] [Related]

  • 10. Botulinum toxin A in the treatment of sialorrhea.
    Benson J, Daugherty KK.
    Ann Pharmacother; 2007 Jan 01; 41(1):79-85. PubMed ID: 17190848
    [Abstract] [Full Text] [Related]

  • 11. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B.
    Wilken B, Aslami B, Backes H.
    Neuropediatrics; 2008 Aug 01; 39(4):200-4. PubMed ID: 19165707
    [Abstract] [Full Text] [Related]

  • 12. Drooling.
    Lal D, Hotaling AJ.
    Curr Opin Otolaryngol Head Neck Surg; 2006 Dec 01; 14(6):381-6. PubMed ID: 17099344
    [Abstract] [Full Text] [Related]

  • 13. The use of botulinum toxic injection to treat excessive drooling in children with neurological conditions.
    Khan A, Pawar G.
    W V Med J; 2005 Dec 01; 101(6):258-60. PubMed ID: 16625812
    [Abstract] [Full Text] [Related]

  • 14. Pediatric Sialorrhea: Submandibular Duct Rerouting and Intraparotid Botulinum Toxin A Injection With Literature Review.
    Calim OF, Hassouna HNH, Yildirim YS, Dogan R, Ozturan O.
    Ann Otol Rhinol Laryngol; 2019 Feb 01; 128(2):104-112. PubMed ID: 30371109
    [Abstract] [Full Text] [Related]

  • 15. Botulinum toxin type A treatment for Parkinsonian patients with moderate to severe sialorrhea.
    Su CS, Lan MY, Liu JS, Chang CC, Lai SL, Wu HS, Chen SS, Chang YY.
    Acta Neurol Taiwan; 2006 Sep 01; 15(3):170-6. PubMed ID: 16995596
    [Abstract] [Full Text] [Related]

  • 16. Successful management of drooling with botulinum toxin A in neurologically disabled children.
    Ellies M, Rohrbach-Volland S, Arglebe C, Wilken B, Laskawi R, Hanefeld F.
    Neuropediatrics; 2002 Dec 01; 33(6):327-30. PubMed ID: 12571790
    [Abstract] [Full Text] [Related]

  • 17. Sialorrhea: a review of a vexing, often unrecognized sign of oropharyngeal and esophageal disease.
    Boyce HW, Bakheet MR.
    J Clin Gastroenterol; 2005 Feb 01; 39(2):89-97. PubMed ID: 15681902
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Saliva control issues in the neurologically challenged. A 30 year experience in team management.
    Crysdale WS, McCann C, Roske L, Joseph M, Semenuk D, Chait P.
    Int J Pediatr Otorhinolaryngol; 2006 Mar 01; 70(3):519-27. PubMed ID: 16146657
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.